Tradename | Company | Number | Date | Products |
---|---|---|---|---|
RAYOS | Horizon Therapeutics Public | N-202020 DISCN | 2012-07-26 | 3 products, RLD |
PARACORT | Pfizer | N-010962 DISCN | 1982-01-01 | 1 products |
DELTASONE | Pharmacia & Upjohn | N-009986 DISCN | 1982-01-01 | 5 products, RLD |
PREDNISONE | Roxane Laboratories | N-017109 DISCN | 1982-01-01 | 1 products |
METICORTEN | Merck & Co | N-009766 DISCN | 1982-01-01 | 2 products, RLD |
Brand Name | Status | Last Update |
---|---|---|
deltasone | ANDA | 2018-11-02 |
deltasone 5mg | ANDA | 2020-10-15 |
p- pack prednisone 20mg, 7- day tapering dose pack | ANDA | 2025-02-11 |
prednisone | ANDA | 2025-06-10 |
prednisone prednisone | ANDA | 2024-02-09 |
prednisone prednisone intensol | ANDA | 2025-04-22 |
prednisone tablets, usp, 10 mg | ANDA | 2025-06-17 |
prednisone tablets, usp, 10 mg prednisone tablets, usp, 20 mg prednisone tablets, usp, 5 mg | ANDA | 2025-05-22 |
prednisone tablets, usp, 20 mg | ANDA | 2025-06-10 |
prednisone tablets, usp, 5 mg | ANDA | 2025-05-15 |
Code | Description |
---|---|
G2112 | Patient receiving <=5 mg daily prednisone (or equivalent), or ra activity is worsening, or glucocorticoid use is for less than 6 months |
G2113 | Patient receiving >5 mg daily prednisone (or equivalent) for longer than 6 months, and improvement or no change in disease activity |
G9468 | Patient not receiving corticosteroids greater than or equal to 10 mg/day of prednisone equivalents for 60 or greater consecutive days or a single prescription equating to 600 mg prednisone or greater for all fills |
G9470 | Patients not receiving corticosteroids greater than or equal to 10 mg/day of prednisone equivalents for 60 or greater consecutive days or a single prescription equating to 600 mg prednisone or greater for all fills |
J7512 | Prednisone, immediate release or delayed release, oral, 1 mg |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Multiple sclerosis | D009103 | EFO_0003885 | G35 | — | — | — | 1 | — | 1 |
Relapsing-remitting multiple sclerosis | D020529 | EFO_0003929 | — | — | — | — | 1 | — | 1 |
Sclerosis | D012598 | — | — | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Lymphoma | D008223 | — | C85.9 | — | 1 | 1 | — | — | 2 |
Prostatic neoplasms | D011471 | — | C61 | — | — | 2 | — | — | 2 |
Non-hodgkin lymphoma | D008228 | — | C85.9 | — | — | 1 | — | — | 1 |
Mantle-cell lymphoma | D020522 | — | C83.1 | — | — | 1 | — | — | 1 |
Allergic rhinitis | D065631 | — | J30.9 | — | — | 1 | — | — | 1 |
Rhinitis | D012220 | EFO_0008521 | J31 | — | — | 1 | — | — | 1 |
Allergic rhinitis perennial | D012221 | EFO_1001417 | J30.89 | — | — | 1 | — | — | 1 |
Asthma | D001249 | EFO_0000270 | J45 | — | 1 | 1 | — | — | 1 |
Bronchitis | D001991 | — | J40 | — | 1 | 1 | — | — | 1 |
Pulmonary eosinophilia | D011657 | EFO_0007257 | J82.81 | — | 1 | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Lupus nephritis | D008181 | EFO_0005761 | — | — | 1 | — | — | — | 1 |
Systemic lupus erythematosus | D008180 | EFO_0002690 | M32 | — | 1 | — | — | — | 1 |
Nephritis | D009393 | — | N05 | — | 1 | — | — | — | 1 |
Hodgkin disease | D006689 | — | C81 | — | 1 | — | — | — | 1 |
Drug common name | Prednisone |
INN | prednisone |
Description | Prednisone is a synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid. It has a role as a prodrug, an anti-inflammatory drug, an antineoplastic agent, an immunosuppressive agent and an adrenergic agent. It is a 20-oxo steroid, an 11-oxo steroid, a 21-hydroxy steroid, a 17alpha-hydroxy steroid, a glucocorticoid, a 3-oxo-Delta(1),Delta(4)-steroid, a primary alpha-hydroxy ketone, a tertiary alpha-hydroxy ketone and a C21-steroid. |
Classification | Small molecule |
Drug class | prednisone and prednisolone derivatives |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO |
PDB | — |
CAS-ID | 53-03-2 |
RxCUI | — |
ChEMBL ID | CHEMBL635 |
ChEBI ID | 8382 |
PubChem CID | 5865 |
DrugBank | DB00635 |
UNII ID | VB0R961HZT (ChemIDplus, GSRS) |